Novozymes A/S
Novozymes A/S (NVZMF) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · NVZMF · as of Jun 9, 2026
Key Statistics
Explore Novozymes A/S Data
nvzmf stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 2 · Buy rate: 0.0%
Competitors & Peers
nvzmf competitorsNVZMF
ACRB
AIQUF
AKZOF
AKZOY
APDStock Performance
Full HistoryAbout Novozymes A/S
Novozymes A/S a Danish enterprise established in 1925 and headquartered in Bagsvaerd, is a leading provider of biological solutions, specializing in the production and global distribution of industri…
what is novozymes a/s · nvzmf stock overview · novozymes a/s company profile · who is novozymes a/s ceo · nvzmf OTC · novozymes a/s headquarters · novozymes a/s business segments
About Stock Overview & Key Data
Novozymes A/S (NVZMF) is a Basic Materials company in the Chemicals - Specialty industry, listed on OTC since Oct 15, 2010. As of the latest trading session, NVZMF stock price is $56.36, with a market capitalization of $26.3B. The stock has returned -23.10% over the past 12 months and -9.78% year-to-date.
According to 2 Wall Street analysts, the consensus rating for Novozymes A/S stock is Hold, with an average 12-month price target of $—. In fiscal year 2025, Novozymes A/S reported revenue of $4.2B and net income of $583.6M. For detailed data — including Novozymes A/S revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Novozymes A/S (NVZMF) stock price is $56.36. The stock is traded on OTC under the ticker symbol NVZMF. The 52-week range is $52.10 – $75.97.